|
PL381714A1
|
|
New medical application of derivatives of anthracycline antibiotics
|
|
PL373543A1
|
|
Pharmaceutical compound containing human insulin biosynthetic analogue as well as its application in diabetic treatment
|
|
PL364528A1
|
|
Antibacterial ophtalmic preparation containing an antibiotic and method for its manufacture
|
|
PL359813A1
|
|
UBP1 protease mutant and its coding sequence, their application as well as products and methods for their obtaining
|
|
PL358082A1
|
|
Inclusion bodies as antigenes in nutritional immunization of animals
|
|
PL358081A1
|
|
Inclusion bodies as antigenes in oral immunization of animals
|
|
PL356654A1
|
|
Improved method of receiving benzoic acid and its salts and new semi-finished products used in this method
|
|
PL355939A1
|
|
Improved method of crystallization of cephuroxime salt
|
|
PL355876A1
|
|
Method of getting fragments characterising the DNA under investigation
|
|
PL354719A1
|
|
Oral vaccine and new application of yeast capable of antigen expression
|
|
PL351349A1
|
|
Method of obtaining highly pure crystalline sildenafile - a free base and sildenafile citrate
|
|
PL346386A1
|
|
Method of obtaining novel derivatives of benzoic acid
|
|
PL342419A1
|
|
Method of obtaining a representation of dna fragments characteristic for a given genome, in particular that of bacteria
|
|
PL342205A1
|
|
Method of purifying daunorubicin hydrochloride
|
|
PL340746A1
|
|
Method of obtaining a derivative of pyrazole pyrimidinone
|
|
PL336061A1
|
|
Method of obtaining cephuroxime 1-acetoxyethylenic ester
|
|
PL334427A1
|
|
Method of determining isomers in ß-lactamic antibiotics of cephalosporin group
|
|
PL332717A1
|
|
Method of isolating 1-acetyloxyethyl bromide
|
|
PL331688A1
|
|
Method of obtaining 6-0-alkyl erythromycin a
|
|
PL331460A1
|
|
Method of obtaining semi-synthetic cephalopsporin
|
